Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Guille

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Histopathology|November 6, 2018
Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolutionLuc Xerri, José Adélaïde, Morgan Avenin, et al.
The American Journal of Surgical Pathology|December 2, 2017
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell TumorsLuc Xerri, José Adélaïde, Cornel Popovici, et al.
Life Science Alliance|July 2, 2026
TERT drives liver tumorigenesis beyond telomere elongationLaura Braud, Julien Vernerey, Arnaud Guille, et al.
Frontiers in Oncology|April 3, 2023
<i>BRCA1</i>-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparibCarolina Velazquez, Esin Orhan, Imene Tabet, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Targeted molecular characterization shows differences between primary and secondary myelofibrosisFrédéric Courtier, Séverine Garnier, Nadine Carbuccia, et al.
Molecular Oncology|February 5, 2022
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II studyRenaud Sabatier, Cécile Vicier, Séverine Garnier, et al.
Journal of Translational Medicine|October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapyFrançois Bertucci, Arnaud Guille, Florence Lerebours, et al.
The American Journal of Surgical Pathology|November 20, 2021
Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in TransdifferentiationCamille Laurent, Charlotte Syrykh, Maxime Hamon, et al.
Molecular Cancer Therapeutics|May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug ConjugateOlivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Journal of the Neurological Sciences|March 8, 2022
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapyBrice Chanez, Romain Appay, Arnaud Guille, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Histopathology|November 6, 2018
Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolutionLuc Xerri, José Adélaïde, Morgan Avenin, et al.
The American Journal of Surgical Pathology|December 2, 2017
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell TumorsLuc Xerri, José Adélaïde, Cornel Popovici, et al.
Life Science Alliance|July 2, 2026
TERT drives liver tumorigenesis beyond telomere elongationLaura Braud, Julien Vernerey, Arnaud Guille, et al.
Frontiers in Oncology|April 3, 2023
<i>BRCA1</i>-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparibCarolina Velazquez, Esin Orhan, Imene Tabet, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Targeted molecular characterization shows differences between primary and secondary myelofibrosisFrédéric Courtier, Séverine Garnier, Nadine Carbuccia, et al.
Molecular Oncology|February 5, 2022
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II studyRenaud Sabatier, Cécile Vicier, Séverine Garnier, et al.
Journal of Translational Medicine|October 28, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapyFrançois Bertucci, Arnaud Guille, Florence Lerebours, et al.
The American Journal of Surgical Pathology|November 20, 2021
Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in TransdifferentiationCamille Laurent, Charlotte Syrykh, Maxime Hamon, et al.
Molecular Cancer Therapeutics|May 9, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug ConjugateOlivier Cabaud, Ludovic Berger, Emerence Crompot, et al.
Journal of the Neurological Sciences|March 8, 2022
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapyBrice Chanez, Romain Appay, Arnaud Guille, et al.
Pageof 5